OpenAlex
PricingAboutJobs
Log inGet started
Work

Supplementary Table 5 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

HTML

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 5 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
DOI: 10.1158/0008-5472.22386746
Authors: Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas, Chris Harbron, Sarah Runswick, Darren Hodgson, Christine Chresta, Rose McCormack, Natalie Byrne, Mark Cockerill, Alexander Graham, Garry Beran, Andrew Cassidy, Carolyn Haggerty, Helen Brown, Gillian Ellison, Judy Dering, Barry S. Taylor, Mitchell Stark, Vanessa Bonazzi, Sugandha Ravishankar, Leisl Packer, Feng Xing, David B. Solit, Richard S. Finn, Neal Rosen, Nicholas K. Hayward, Tim French, Paul D. Smith
Institutions: QIMR Berghofer Medical Research Institute, Memorial Sloan Kettering Cancer Center, Dipartimento dell Educazione della Cultura e dello Sport, AstraZeneca (United Kingdom), University of California, Los Angeles
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: gold

Funders: Memorial Sloan-Kettering Cancer Center, Cancer Research UK, University of California, Los Angeles
OpenAlex ID: W4361241590
Cites: 36
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms